Park, Sung P <br/><br/>
Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion.  [electronic resource] 

 -  Clinical & experimental ophthalmology  Jul 2009 
 - 490-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1442-9071 
<br/><br/><label>Standard No.: </label>10.1111/j.1442-9071.2009.02061.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Angiogenesis Inhibitors--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Aqueous Humor--metabolism<br/>Bevacizumab<br/>Enzyme-Linked Immunosorbent Assay<br/>Eye Proteins--metabolism<br/>Female<br/>Humans<br/>Macular Edema--drug therapy<br/>Male<br/>Middle Aged<br/>Nerve Growth Factors--metabolism<br/>Prognosis<br/>Retinal Vein Occlusion--complications<br/>Serpins--metabolism<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors